Results
|
2301.
|
|
|
2302.
|
Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor. [electronic resource] by
- Muto, Akihiro
- Hori, Mayumi
- Sasaki, Yosuke
- Saitoh, Akari
- Yasuda, Iho
- Maekawa, Tadahito
- Uchida, Tomoe
- Asakura, Keiko
- Nakazato, Tomonori
- Kaneda, Toshio
- Kizaki, Masahiro
- Ikeda, Yasuo
- Yoshida, Tadashi
Producer: 20070620
In:
Molecular cancer therapeutics vol. 6
Availability: No items available.
|
|
2303.
|
|
|
2304.
|
|
|
2305.
|
|
|
2306.
|
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. [electronic resource] by
- Niessner, Heike
- Beck, Daniela
- Sinnberg, Tobias
- Lasithiotakis, Konstantinos
- Maczey, Evelyn
- Gogel, Jeannette
- Venturelli, Sascha
- Berger, Alexander
- Mauthe, Mario
- Toulany, Mahmoud
- Flaherty, Keith
- Schaller, Martin
- Schadendorf, Dirk
- Proikas-Cezanne, Tassula
- Schittek, Birgit
- Garbe, Claus
- Kulms, Dagmar
- Meier, Friedegund
Producer: 20110310
In:
The Journal of investigative dermatology vol. 131
Availability: No items available.
|
|
2307.
|
Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIPL and Mcl-1. [electronic resource] by
- Jang, Ji Hoon
- Lee, Tae Jin
- Yang, Eun Sun
- Min, Do Sik
- Kim, Young Ho
- Kim, Sang Hyun
- Choi, Yung Hyun
- Park, Jong-Wook
- Choi, Kyeong Sook
- Kwon, Taeg Kyu
Producer: 20100729
In:
Experimental cell research vol. 316
Availability: No items available.
|
|
2308.
|
|
|
2309.
|
|
|
2310.
|
|
|
2311.
|
|
|
2312.
|
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. [electronic resource] by
- Wertz, Ingrid E
- Kusam, Saritha
- Lam, Cynthia
- Okamoto, Toru
- Sandoval, Wendy
- Anderson, Daniel J
- Helgason, Elizabeth
- Ernst, James A
- Eby, Mike
- Liu, Jinfeng
- Belmont, Lisa D
- Kaminker, Josh S
- O'Rourke, Karen M
- Pujara, Kanan
- Kohli, Pawan Bir
- Johnson, Adam R
- Chiu, Mark L
- Lill, Jennie R
- Jackson, Peter K
- Fairbrother, Wayne J
- Seshagiri, Somasekar
- Ludlam, Mary J C
- Leong, Kevin G
- Dueber, Erin C
- Maecker, Heather
- Huang, David C S
- Dixit, Vishva M
Producer: 20110321
In:
Nature vol. 471
Availability: No items available.
|
|
2313.
|
|
|
2314.
|
|
|
2315.
|
Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1. [electronic resource] by
- Huber, S
- Oelsner, M
- Decker, T
- zum Büschenfelde, C Meyer
- Wagner, M
- Lutzny, G
- Kuhnt, T
- Schmidt, B
- Oostendorp, R A J
- Peschel, C
- Ringshausen, I
Producer: 20110809
In:
Leukemia vol. 25
Availability: No items available.
|
|
2316.
|
A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2. [electronic resource] by
- Holkova, Beata
- Supko, Jeffrey G
- Ames, Matthew M
- Reid, Joel M
- Shapiro, Geoffrey I
- Perkins, Edward Brent
- Ramakrishnan, Viswanathan
- Tombes, Mary Beth
- Honeycutt, Connie
- McGovern, Renee M
- Kmieciak, Maciej
- Shrader, Ellen
- Wellons, Martha D
- Sankala, Heidi
- Doyle, Austin
- Wright, John
- Roberts, John D
- Grant, Steven
Producer: 20130927
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
2317.
|
|
|
2318.
|
|
|
2319.
|
|
|
2320.
|
|